Effects of Reslizumab on Asthma Outcomes in a Subgroup of Eosinophilic Asthma Patients with Self-Reported Chronic Rhinosinusitis with Nasal Polyps
- 1 February 2019
- journal article
- research article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 7 (2) , 589-596.e3
Abstract
No abstract availableKeywords
Funding Information
- Teva Pharmaceutical Industries
- Roche
- Boehringer Ingelheim
- F. Hoffmann-La Roche
- Sanofi
- AstraZeneca
- Takeda Pharmaceuticals U.S.A.
- Cephalon
- Genentech
- MedImmune
- North Carolina GlaxoSmithKline Foundation
- Actelion Pharmaceuticals
- Novartis
- Merck
This publication has 44 references indexed in Scilit:
- Chronic rhinosinusitis: From one disease to different phenotypesPediatric Allergy and Immunology, 2012
- Association between Severity of Asthma and Degree of Chronic RhinosinusitisAmerican Journal of Rhinology & Allergy, 2011
- Chemokine CC‐ligand 5 production and eosinophil activation into the upper airways of aspirin‐sensitive patientsClinical & Experimental Allergy, 2009
- Relationships between Severity of Chronic Rhinosinusitis and Nasal Polyposis, Asthma, and AtopyAmerican Journal of Rhinology & Allergy, 2009
- Expression of 5‐lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin‐intolerant asthmaThe Journal of Pathology, 2006
- Aspirin sensitivity and severity of asthma: Evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthmaJournal of Allergy and Clinical Immunology, 2005
- Enhanced soluble interleukin‐5 receptor alpha expression in nasal polyposisAllergy, 2003
- Regulation of IL-5 Receptor on Eosinophil Progenitors in Allergic Inflammation: Role of Retinoic AcidInternational Archives of Allergy and Immunology, 2001
- Rhinosinusitis in severe asthmaJournal of Allergy and Clinical Immunology, 2001
- Determining a minimal important change in a disease-specific quality of life questionnaireJournal of Clinical Epidemiology, 1994